Taken overall, IL4I1 might activate CCL2-CCR2 via JAK1/STAT3 signaling pathway further to promote M2-like macrophages polarization which enhances ccRCC immune escape and malignant behaviors. Here, JAK1 is linked to nonpapillary renal cell carcinoma.